An Innovative Therapy for
People with Parkinson’s Disease

Non-invasive therapy targets functional improvement.

Exploring Treatments for Other Neurodegenerative Diseases

Clinical-stage treatments for patient relief.

A Growth Opportunity for the Right Partners

Addressing urgent unmet needs in a growing patient population.

NEWS – FDA grants Breakthrough designation for specialized phototherapy.

Ours is the first specialized phototherapy treatment to achieve this status. Sign up to be among the first to know when our Phase 3 study recruiting begins. Learn More >

ADDRESSING MAJOR UNMET NEEDS

A Potential New Therapy for People Living with Parkinson’s Disease

Parkinson’s disease is both a motor and a non-motor disorder.

Over 10 million people live with Parkinson’s disease (PD). While most benefit from treatment with dopaminergic drugs, people with PD continue to experience difficulties with unresolved motor symptoms and non-motor symptoms (e.g., sleep disorders, fatigue, and mood and cognitive problems). Impaired function and reduced quality of life often prevent those living with PD from working, exercising, socializing, and doing the things they want to do.

In clinical trials, the proprietary specialized phototherapy technology built into our therapeutic device, Celeste®, improved the non-motor symptoms of Parkinson’s disease and improved quality of life for people with PD.

We invite you to join us in our efforts to improve the quality of life for people living with PD by getting this breakthrough into their hands as soon as possible. Investors, inquire here.

Seeing Specialized Phototherapy Clearly

Our non-invasive specialized phototherapy is well on its way to becoming a physician-prescribed standard of care.
When it comes to motor and non-motor symptoms of Parkinson’s, here’s what we’re seeing so far.

PROMISING RESULTS

Research participants experienced clinically meaningful improvement in combined motor and non-motor function and enjoyed improved quality of life.

NON-INVASIVE

Those who added specialized phototherapy to their existing drug regimen experienced no major device-related side-effects or negative interactions with their current prescriptions.

LIFESTYLE FRIENDLY PROTOCOL

Research participants found our device safe and convenient to use while watching TV, reading, using a smart phone, or other seated activities.

Learn more about the wide variety of motor and non-motor symptoms associated with Parkinson’s.

Stay Connected

Sign up here to keep in touch. We may periodically send you notifications of upcoming clinical trials, research, and product releases.

Trending Topics

How Parkinson’s Affects Sleep and Vice-Versa

How Parkinson’s Affects Sleep and Vice-Versa

When most people think of Parkinson’s Disease (PD), the first symptom to come to mind are physical tremors and other movement symptoms. However, most people with Parkinson’s experience a wide range of non-motor symptoms that can often be more disruptive to their daily...

Care for the caregivers

Care for the caregivers

“What would I do without my caregiver?” Many people with Parkinson’s disease ask themselves some form of this question every single day. Caregivers come in all shapes and forms, but they all have one thing in common: The work they do is absolutely critical. But it’s...

“Breaking Through the FDA” (Biosphere, 2021)

“Breaking Through the FDA” (Biosphere, 2021)

Innovative medical devices and diagnostics can get to patients and providers sooner under the U.S. Food and Drug Administration’s (FDA) Breakthrough Device Program. The program provides a special regulatory Breakthrough Device Designation for medical products that...

PhotoPharmics Appoints Dr. Karl Kieburtz as Chief Medical Officer

PhotoPharmics Appoints Dr. Karl Kieburtz as Chief Medical Officer

View full press release on Businesswire. PhotoPharmics Appoints Dr. Karl Kieburtz as Chief Medical Officer World-renowned neurologist and movement disorders specialist joins PhotoPharmics as company advances breakthrough device through pivotal clinical trial and to...